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Abstract
Background: Musculoskeletal (MSK) conditions are the most frequently reported chronic conditions and one of the
biggest causes of disability in the UK. Given the ageing population and the impact of these problems, the demand
for MSK treatment will rise. Despite reduced waiting times, MSK pathways have remained variable and inconsistent
and need to be improved to meet patient needs. The aim of this systematic review is to understand the evidence
for the effectiveness of current models of service delivery and care pathways for adult hip/knee pain patients
accessing secondary care for specialist opinions.
Methods: MEDLINE, MEDLINE In-Process, CINAHL, Embase, PEDro, PubMed, Web of Science, Cochrane Central and
HMIC databases will be searched without language restrictions for papers published from 1990 onward. Websites
will be reviewed for grey literature including care pathways, policy documents and unpublished MSK research.
Additionally, reference lists will be checked and citations tracked for included studies.
Discussion: The following evidence will be included: research considering care pathways at the intersection
between primary and secondary care for adults with hip and/or knee pain in countries with an established clinical
pathway. Studies considering generalised inflammatory arthropathy and post-surgical care pathways will be
excluded. Screening for included data will be conducted independently by two reviewers. After benchmarking,
quality assessment and data extraction will be conducted by one reviewer and checked by a second. A mixed
method analysis will be conducted.
This systematic review will be used as part of a programme of research to identify best practice for MSK hip and
knee pain care pathways. It will provide recommendations for pathway re-design to meet patient needs and ensure
efficient streamlining of the patient journey. The review will combine a wide range of information sources including
patient and clinician opinion, clinical guidelines, health service delivery research and stakeholder requirements. This
should result in a pathway that provides better patient experience and outcomes, whilst meeting the demands
placed on the NHS for high-quality evidence-based interventions with efficient use of resources.
Systematic review registration: PROSPERO CRD42016035510
Keywords: Musculoskeletal, Hip pain, Knee pain, Care pathway, Service delivery
* Correspondence: buttonk@cardiff.ac.uk
1School of Healthcare Sciences, Cardiff University, Eastgate House, Newport
Road, Cardiff CF24 0AB, UK
2Trauma and Orthopaedics, Cardiff and Vale Orthopaedic Centre, University
Hospital Llandough, Cardiff and Vale UHB, Cardiff, UK
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Button et al. Systematic Reviews  (2016) 5:128 
DOI 10.1186/s13643-016-0301-x
Introduction
Musculoskeletal (MSK) conditions are common and are
one of the biggest causes of disability [1]. In the UK, an
estimated 30.6 million working days are lost annually
through these disorders [2], and they are the second lar-
gest cause of global years lived with disability [1]. Studies
have shown that approximately 30 % of consultations with
a general practitioner are about MSK complaints [3]. Knee
and hip osteoarthritis represents one of the biggest bur-
dens alongside low back problems, impacting on pain,
function and quality of life [4, 5]. Given projected in-
creases in the numbers and proportions of older people in
the population, the impact of these problems and the de-
mand for MSK treatment are both likely to rise [4].
Current UK treatment guidance advises that patients
with osteoarthritis-related hip and knee pain should be
managed in primary care, by the appropriate health pro-
fessional [6]. If a specialist opinion is required, then the
patient will be referred for assessment in a triage clinic,
at the interface between primary and secondary care. In
the triage clinic, a patient may be seen by any one of a
range of healthcare professionals who specialise in MSK
conditions. The outcome of this consultation could be a
care recommendation such as further investigation, im-
aging, physiotherapy, injections, medical devices or rec-
ommendation for surgical management [3, 6]. Despite
guidance having been available for several years, it is
clear that multiple pathways are being used inconsist-
ently to manage MSK patient care, with a lack of uni-
formity across different regions [3]. In more general
terms, it has also been observed that health services are
arranged around structures that are already in place, ra-
ther than the needs of the patients receiving the care.
This failure to consider the level of need required can
result in over- or less effective treatment [7].
Given the rising numbers seeking treatment and the
pressure this will place on National Health Service
(NHS) resources, it is essential that the care pathway for
those experiencing hip and knee pain is based on robust
evidence [3]. A recent systematic review evaluating the
role of allied health professionals in interface clinics for
MSK conditions found that the clinics were well re-
ceived by patients, were cost effective and did have the
potential to improve outcome. However, these findings
were based on a low level of evidence [8].
The need to re-design the pathway for MSK conditions,
to make sure that the patient sees the right clinician, at
the correct stage in their condition management, was
highlighted in a Canadian cohort study. The study, which
evaluated the consultation outcomes of orthopaedic con-
sultants, found that 79.3 % of the patients assessed did not
go on to have surgery within 18 months of the consult-
ation. It concluded that further research was needed on
both the best model of care and how to use the scarce and
expensive resource of the orthopaedic surgeon most ap-
propriately [9].
When re-designing the pathway, consideration of pa-
tient values, beliefs and needs are also very important. The
authors in [10], exploring the illness beliefs in patients
with knee osteoarthritis, found that many individuals there
shared a strong belief that surgery was an unattractive
treatment option. This is crucially important given that re-
ferrals to specialist care often result in automatic surgical
assessment. Findings such as these support the need for a
care pathway that begins with patients having the oppor-
tunity to explore conservative treatment first.
None of the previous systematic reviews in this field
have specifically explored care pathways and evaluated
evidence from all the different aspects of healthcare de-
livery that need to be considered: patient needs, service
organisation, outcomes and costs. If the hip and knee
pain care pathway is to be re-designed effectively to
meet future healthcare needs, it is crucial to have a full
picture of the existing evidence.
This systematic review is part of a programme of re-
search for patient and public benefit that is being funded
by Health and Care Research Wales. The aim of the re-
view is (1) to understand the evidence for the effectiveness
of current models of service delivery and care pathways
for adult hip/knee pain patients accessing secondary care
for specialist opinions and (2) to identify the key informa-
tion required for effective referral decisions to ensure the
most appropriate intervention for individual patients.
This data will be used to re-design the care pathway
for patients with hip and knee pain from the point of re-
ferral for specialist care.
Methods
This systematic review protocol has been designed in ac-
cordance with the Preferred Reporting Items for Systematic
Review and Meta-Analysis Protocols (PRISMA-P) guidance
[11]. The PRISMA-P is included as Additional file 1.
Search strategy
Searches will be conducted for journal publications and
grey literature investigating models of service delivery
and care pathways. All sources will be searched without
language restrictions for evidence published from 1990
onward. The choice of 1990 as the start date for the
search is based on the understanding that care pathways
started to be introduced in the early part of the decade
[12]. The following databases will be searched: MEDLINE,
MEDLINE In-Process, Cumulative Index to Nursing and
Allied Health Literature (CINAHL) Embase, PEDro,
PubMed, Web of Science, Cochrane Central Register of
Controlled Trials and Health Management Information
Consortium (HMIC).
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Using a range of resources including TerMine [13] to
identify keywords and Yale MeSH Analyzer [14] for
indexed terms, the search terms have been developed in
Ovid MEDLINE (Table 1) and will be adapted to the
other databases. The Ovid MEDLINE strategy was
checked, using a set of relevant papers, to ensure a rea-
sonable balance of sensitivity (ability to pick up known
relevant studies) and precision (number of papers
needed to screen per relevant paper). It is notable that
the terms include triage as both a keyword and an
indexed term in two sections of the strategy. This is de-
liberate because they are used (i) to describe the deci-
sions taken within a care pathway and (ii) specifically to
identify a move from primary to secondary care.
In addition to searching databases, a range of supple-
mentary techniques will be employed. The following
websites will be searched for grey literature, care path-
ways and policy documents using keywords and poten-
tially relevant results identified:
AHRQ National Guidelines Clearinghouse http://
www.guideline.gov/
Arthritis Australia www.arthritisaustralia.com.au/
Arthritis Care UK http://www.arthritiscare.org.uk/
Arthritis Foundation www.arthritis.org
Arthritis National Research Foundation http://www.
curearthritis.org/
Arthritis New Zealand www.arthritis.org.nz/
Arthritis Research UK http://www.arthritisresearchuk.org/
Arthritis Society www.arthritis.ca/
European Pathway Association http://www.e-p-a.org/
Open Clinical http://www.openclinical.org/clinicalpath
ways.html
OpenGrey http://www.opengrey.eu/
NICE Evidence Search https://www.evidence.nhs.uk/
TRIP database https://www.tripdatabase.com/
Finally, for included papers and documents, reference
lists will be checked, citations tracked and authors con-
tacted to identify additional evidence.
A log of all searches will be kept with details of search
terms used for each database or website. The results will
be exported to an electronic database (EndNote version
X7.1, Thomson Reuters, New York) for storage and man-
agement of all identified citations.
Eligibility
The review will consider all study designs and documents
that look at care pathways for MSK hip and/or knee pain
for adults aged 18 and over accessing secondary care for
specialist opinion. A MSK pathway generally accepts all
hip/knee pain without requiring specific diagnostic cri-
teria. The European Pathway Association defines a care
pathway as “a methodology for the mutual decision mak-
ing and organization of care for a well-defined group of
patients for a well-defined period” [15].
Publications looking at the following will be excluded:
generalised inflammatory arthropathy, stroke and MSK
care pathways that do not include the hip and knee joint
or which focus on post-surgical care.
Table 1 Search terms: Ovid MEDLINE
MEDLINE
# Searches
1 musculoskeletal.ti,ab.
2 hip.ti,ab.
3 knee.ti,ab.
4 orthopaedic.ti,ab.
5 orthopedic.ti,ab.
6 musculoskeletal diseases/
7 musculoskeletal pain/
8 or/1-7
9 (Care adj3 (map* or pathway* or protocol* or access*)).ti,ab.
10 (clinic* adj3 (standard* or pathway* or assessment* or map*
or protocol*)).ti,ab.
11 ((critical or patient*) adj3 pathway).ti,ab.
12 (screening adj3 (service* or standard* or protocol*)).ti,ab.
13 triage.ti,ab.
14 critical pathways/
15 triage/
16 or/9-15
17 triage.ti,ab.
18 MCAT.ti,ab.
19 MCASS.ti,ab.
20 conversion rate.ti,ab.
21 (extended scope adj3 physiotherap*).ti,ab.
22 (orthop?edic adj (consultation or surgeon)).ti,ab.
23 MCAS.ti,ab.
24 CATS.ti,ab.
25 (primary adj2 secondary).ti,ab.
26 primary-secondary.ti,ab.
27 (refer adj6 (GP or general practi* or primary care or outpatient
or consultation or nurse practitioner*)).ti,ab.
28 ambulatory care/or ambulatory care facilities/
29 “referral and consultation”/
30 triage/
31 or/17-30
32 8 and 16 and 31
33 limit 32 to yr=1990-2016
34 exp fractures, bone/
35 exp emergency services, hospital/
36 (fracture* or emergency).ti.
37 or/34-36
38 33 not 37
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Data selection
After duplicate results are removed, titles and abstracts
will be reviewed independently by two reviewers to de-
termine whether they meet the eligibility criteria. All pa-
pers and documents potentially meeting the criteria will
be obtained in full text and reviewed for inclusion by
two independent reviewers. At both the title/abstract
and full-text stages, cases of disagreement will be re-
solved by discussion with a third reviewer.
The data selection process will be documented using
the PRISMA flow diagram [16]. A record will be kept of
all items excluded at full text with the reason for their
exclusion.
Quality assessment
Quality assessment will be conducted using validated
checklists for specific research designs (e.g. randomised
controlled trials, qualitative studies, cross-sectional sur-
veys, longitudinal studies, case series). The forms will be
pilot tested to ensure a baseline of understanding and
agreement between reviewers is achieved. Following this,
studies will be assessed by one reviewer with that assess-
ment being checked by a second reviewer.
Data extraction
Evidence will be extracted directly into an agreed form.
Template forms for different study designs have been
developed by team members and used in previous re-
search. These forms will be adapted and agreed to en-
sure all appropriate data are collected. As with quality
assessment, the form will be pilot tested on a sample set
of studies to ensure a baseline of understanding and
agreement between reviewers is achieved. After piloting,
each data extraction form will be completed by one re-
viewer and checked for accuracy by another.
It is anticipated that data relating to the following out-
comes will be extracted: patient experience, expectations,
illness beliefs and satisfaction, consultation outcomes
(numbers/resources triaged), costs and utilisation of work-
force and healthcare resources. If additional outcomes are
identified, data for these outcomes will also be extracted.
Given the scope of the review, no primary outcome has
been defined.
Data synthesis
Data synthesis will be conducted in three phases: effect-
iveness, participant views and a cross-study synthesis as
outlined by Kavanagh et al. [17].
Effectiveness
If appropriate to do so (judged qualitatively on the basis
of similarity of study design, population included, inter-
vention applied and outcomes measured), meta-analysis
will be conducted using the Cochrane Collaboration’s
Review Manager. A random effect model will be utilised.
Where outcomes are comparable between studies, mea-
sures for continuous data will be presented as mean differ-
ences (or standardised mean differences as appropriate),
95 % confidence intervals (CIs) and p values. For dichot-
omous data, results will be presented as relative risks with
95 % CIs and p values. Meta-analysis results will be pre-
sented using forest plots, with embedded risk of bias
traffic light tables. Heterogeneity will be quantified and re-
ported using the I2 statistic. If more than 10 studies are
identified for meta-analysis, publication bias will be visu-
ally explored using a funnel plot.
Attrition rates will be recorded for included studies,
and if necessary, a sensitivity analysis will be conducted
to consider the impact of including studies with substan-
tial levels of missing data (attrition rates greater than
20 %). As far as possible, analyses will be based on
intention to treat with all participants analysed in their
allocated groups.
Intervention papers will coded for outcomes and
demographic data using NVivo 10 software (QSR Inter-
national, Doncaster, Australia).
Participant views
A broad evidence synthesis of view studies (qualitative,
correlation, cross-sectional surveys and process evalua-
tions) will be undertaken. Where applicable, data gathered
from quantitative studies will be analysed thematically and
integrated with the key findings from qualitative studies.
Data synthesis will be dependent on the nature of the evi-
dence available. If the body of evidence is sparse and does
not share common interventions or themes, a narrative
description of the themes in each paper will be presented.
Where the evidence is sufficiently rich and shares com-
mon themes, a thematic synthesis will be performed.
An index ladder of codes will be developed a priori, in
accordance with Richie and Spencer [18], so that key
findings can be extracted and organised at the same
time. The index ladder of codes will be developed after
reading a sample of eligible papers and discussion with
the team. The coded findings will be read and re-read by
at least two members of the team, and categories may be
further refined and organised. The coding framework
may also be modified during coding as new themes
emerge. Themes will be coded in NVivo by one reviewer
and checked by another.
An aggregative rather than an interpretive approach to
synthesis will be used [19] bringing together and reflect-
ing the nature of evidence identified, but not developing
theoretical concepts.
Cross-study synthesis
The final synthesis will juxtapose the findings of the two
syntheses against one another to identify interventions
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and solutions that answer the needs of the target popula-
tion. This will be presented as a table or matrix dependent
on the findings.
Registration
The protocol for the systematic review and meta-
analysis has been registered with PROSPERO, the inter-
national prospective register of systematic reviews
(PROSPERO 2015: CRD42016035510), available from
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?
ID=CRD42016035510.
Protocol amendments
Important variations from the published protocol will be
reported in the systematic review.
Discussion
This systematic review will provide a full picture of the
current evidence considering care pathways for hip and/
or knee pain at the interface between primary and sec-
ondary care. That picture will highlight evidence about
which aspects of the pathway work well, what is not
working well and key areas for future research. To date,
no systematic review has provided a comprehensive ana-
lysis that synthesises service delivery and organisation
with service user requirements and opinion.
This review is part of a programme of research that is
being funded by Health and Care Research Wales. The re-
sults will provide data for effective care pathway re-design,
by identifying the best model of care. The work will be en-
hanced by development of a decision aid to support infor-
mation exchange and efficient referral of patients across
the pathway. To achieve this, the findings of the system-
atic review will be combined with data from service user
experience and the key information required to inform re-
ferral decisions for these patient groups.
Ultimately, this should result in a pathway that pro-
vides better patient experience and outcomes, whilst
meeting the demands placed on the NHS for high-
quality evidence-based interventions with efficient use of
resources.
Additional file
Additional file 1: PRISMA reporting checklist. (DOC 107 kb)
Abbreviations
CINAHL, Cumulative Index to Nursing and Allied Health Literature; MeSH,
Medical Subject Headings; MSK, musculoskeletal; NHS, National Health
Service; PRISMA-P, Preferred Reporting Items for Systematic review and
Meta-Analysis Protocols
Acknowledgements
Health and Care Research Wales.
Funding
This systematic review is being funded by a Health and Care Research Wales
research for patient and public benefit.
Availability of data and materials
Not applicable
Authors’ contributions
KB is the guarantor and KB, FM HH, ALW and SJ designed the protocol for
this systematic review. KB and FM were responsible for writing this
publication. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable
Ethics approval and consent to participate
Not applicable
Author details
1School of Healthcare Sciences, Cardiff University, Eastgate House, Newport
Road, Cardiff CF24 0AB, UK. 2Trauma and Orthopaedics, Cardiff and Vale
Orthopaedic Centre, University Hospital Llandough, Cardiff and Vale UHB,
Cardiff, UK. 3Specialist Unit for Review Evidence (SURE), Cardiff University,
Cardiff, UK.
Received: 23 May 2016 Accepted: 15 July 2016
References
1. Vos T, et al. Years lived with disability (YLDs) for 1160 sequelae of 289
diseases and injuries 1990–2010: a systematic analysis for the global burden
of disease study 2010. Lancet. 2012;380(9859):2163–96.
2. Office for National Statistics (2014). Sickness absence in the labour
market—Office for National Statistics. [online] Available at: http://www.ons.gov.
uk/employmentandlabourmarket/peopleinwork/labourproductivity/articles/
sicknessabsenceinthelabourmarket/2014-02-25 [Accessed 16 May 2016].
3. Briggs T (2012) Getting it right first time: improving the quality of orthopaedic
care within the National Health Service in England. Available at: http://www.
gettingitrightfirsttime.com/downloads/GIRFT-National-Report.pdff [Accessed 04
April 2016].
4. Cross M, Smith E, Hoy D, et al. The global burden of hip and knee
osteoarthritis: estimates from the global burden of disease 2010 study. Ann
Rheum Dis. 2014;0:1–8.
5. Arthritis Research UK. Osteoarthritis in general practice. Data and
perspectives. Chesterfield: Arthritis Research UK; 2013.
6. National Institute for Health & Care Excellence Osteoarthritis. Care and
management in adults (clinical guideline; no. 177). London: NICE; 2014.
7. The Health Foundation. Learning report ‘improving patient flow. How two
trusts focused on flow to improve the quality of care and use available
capacity effectively’. London: The Health Foundation; 2013.
8. Saxon R, et al. Extended roles for allied health professional: an updated
systematic review of the evidence. J Multidiscip Healthc. 2014;7:479–88.
9. Badley E, et al. Surgery or consultation: a population-based cohort study of
use of orthopaedic surgeon services. Plosone online. 2013;8(6):1–8.
10. Pouli N, Das Nair R, Lincoln NB, Walsh D. The experience of living with knee
osteoarthritis: exploring illness and treatment beliefs through thematic
analysis. Disabil Rehabil. 2014;36(7):600–7.
11. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al.
Preferred Reporting Items for Systematic Review and Meta-Analysis
Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
12. Open Clinical: clinical pathways. Last modified 8 Jul 2013. Available: http://
www.openclinical.org/clinicalpathways.html [Last Accessed 4 April 2016].
13. National Centre for Text Mining. TerMine. NACTEM: University of Manchester
2012. Available: http://www.nactem.ac.uk/software/termine/ Last Accessed 4
April 2016.
14. Yale University. Yale MeSH Analyzer. Cushing/Whitney Medical Library, Yale
University, New Haven. 2015. Available: http://mesh.med.yale.edu/ Accessed:
4 April 2016.
Button et al. Systematic Reviews  (2016) 5:128 Page 5 of 6
15. European Pathway Association. Care pathways. Available at: http://e-p-a.org/
care-pathways/ [Last Accessed 4 July 2016]
16. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009).
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the
PRISMA statement. BMJ. 2009;339:b2535.
17. Kavanagh J, Campbell F, Harden A, & Thomas J. (2011), Mixed methods
synthesis: a worked example, In Synthesizing Qualitative Research: Choosing
the Right Approach. Hannes K. and CLockwood C, editors, John Wiley &
Sons, Ltd, Chichester, UK. p. 113–136. doi:10.1002/9781119959847.ch6
18. Richie, J and Spencer, L. (1994), Qualitative data analysis for applied policy
research, In: Bryman A and Burgess RG, editors, Analysing Qualitative Data,
London: Routledge, 173-94.
19. Dixon-Woods M, Agarwal S, Young B, Jones D, Sutton A. Integrative
approaches to qualitative and quantitative evidence. London: Health
Development Agency; 2004.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Button et al. Systematic Reviews  (2016) 5:128 Page 6 of 6
